Advertisement

Cancer Talk

  • October 19: The Week in Cancer News  

    October 19: The Week in Cancer News

    A study investigates cancer care for rural children, and the U.S. Food and Drug Administration approves a new breast cancer therapy.

    by Kate Yandell
  • October 12: The Week in Cancer News  

    October 12: The Week in Cancer News

    A study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.

    by Kate Yandell
  • October 5: The Week in Cancer News  

    October 5: The Week in Cancer News

    Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.

    by Kate Yandell
  • Why I Put Down My Camera  

    Why I Put Down My Camera

    A professional photographer shares advice on living in the moment after caring for his father, who had stage IV lung cancer.

    by Jay Perry
Advertisement

From the AACR

  • Making Mammography Better

    A study investigates whether artificial intelligence can reduce false-positive mammograms.

  • New FDA Approval

    The U.S. Food and Drug Administration has approved a new PARP inhibitor for BRCA-mutant breast cancer.

  • Nobel Prize for Immunotherapy

    James P. Allison, PhD, a Fellow of the AACR Academy, won the 2018 Nobel Prize in Physiology or Medicine for his pioneering work in cancer immunotherapy.

Advertisement

Video

Janet Freeman-Daily: On Lung Cancer and Blame

Advertisement

social media

donate to the AACR

Cancer Progress Report

The AACR Cancer Progress Report 2018, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.

Supporters

... ... ... ... ... ...